LentiCRISPRv2Cre Citations (3)
Originally described in: Systematic in vivo inactivation of chromatin regulating enzymes identifies Setd2 as a potent tumor suppressor in lung adenocarcinoma.Walter DM, Venancio OS, Buza EL, Tobias JW, Deshpande C, Gudiel AA, Kim-Kiselak C, Cicchini M, Yates TJ, Feldser DM Cancer Res. 2017 Feb 15. pii: canres.2159.2016. doi: 10.1158/0008-5472.CAN-16-2159. PubMed Journal
Articles Citing LentiCRISPRv2Cre
| Articles |
|---|
Systematic in vivo inactivation of chromatin regulating enzymes identifies Setd2 as a potent tumor suppressor in lung adenocarcinoma.
Walter DM, Venancio OS, Buza EL, Tobias JW, Deshpande C, Gudiel AA, Kim-Kiselak C, Cicchini M, Yates TJ, Feldser DM.
Cancer Res. 2017 Feb 15. pii: canres.2159.2016. doi: 10.1158/0008-5472.CAN-16-2159.
PubMed
Associated Plasmids |
| Blocking EGFR palmitoylation suppresses PI3K signaling and mutant KRAS lung tumorigenesis. Kharbanda A, Walter DM, Gudiel AA, Schek N, Feldser DM, Witze ES. Sci Signal. 2020 Mar 3;13(621). pii: 13/621/eaax2364. doi: 10.1126/scisignal.aax2364. PubMed |
| Copper is an essential regulator of the autophagic kinases ULK1/2 to drive lung adenocarcinoma. Tsang T, Posimo JM, Gudiel AA, Cicchini M, Feldser DM, Brady DC. Nat Cell Biol. 2020 Apr;22(4):412-424. doi: 10.1038/s41556-020-0481-4. Epub 2020 Mar 16. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.